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International Congress of Eye Research (ICER)’sS e p t e m b e r
2008 meeting in Beijing provided a unique conference of
East meets West on healing approaches in ophthalmology,
and for the first time, a section on complementary medicine
(CM) was added to the program. CM includes all fields of
healing including psychotherapy, hypnosis, meditation and
visual imagery, prayer, acupuncture, herbal remedies and
nutrients, massage therapy, exercise, reiki, and other
measures which may facilitate healing other than traditional
Western medicines and procedures. Before a therapy gains
global acceptance and use, it must withstand the rigor of
scientific investigation and pass through the narrow straits
of peer review and possibly Food and Drug Administration
approval to render it safe and effective. ICER’sg o a lw a st o
encourage investigators of complementary methodology to
cross that threshold. To that end, three CM sessions
included 21 presentations which introduced novel comple-
mentary therapeutic approaches in the treatment of ocular
conditions. This monograph has been designed to feature
some of those presentations.
Immunological mechanisms have been clearly estab-
lished at the core of a number of conditions to include not
only cancer and coronary artery disease but also several
ocular conditions such as uveitis, thyroid eye disease,
keratitis sicca, ocular infections, and more recently for
macular degeneration and glaucoma. Four investigators
have focused on immune mechanisms in ocular disease.
Chun Zhang from Peking University Eye Center presented
his group’s work which explored the balance of Th1 and
Th2 cytokines in glaucoma. Zhang’s group showed altered
levels of cytokines in mild glaucomatous neuropathy. They
suggest the possibility that abnormal immune environments
contribute to the pathophysiology of glaucoma.
The secondgroup,leadby MichalSchwartz,has pioneered
the concept of harnessing the immune system to combat
neurodegeneration in glaucoma. They have shown that
immune deficiency or suppression impair the recovery
process after optic nerve crush, whereas boosting self-
specific immune response, by both passive and active
immunization, promotes recovery. Those same T cells that
can lead to the development of autoimmune disease can
protect neurons under neurodegenerative conditions, and it is
a subpopulation of regulatory T cells which regulates the
autoimmune response to promote protection over injury. Dr.
Schwartz introduces the concept of a therapeutic vaccination
to boost the immune response to facilitate neuroprotection.
This delicate balance of immune protection over injury
may be overridden by physical or emotional stressors. In
1975, from the groundbreaking work of Robert Ader [1]
at New York’s University of Rochester, the field of
psychoneuroimmunology (PNI) was born and has since
become a burgeoning arena in neuroscience research. PNI is
a discipline which describes the relationship between
emotional states, the central and peripheral nervous systems,
and the endocrine and immune systems. The theoretical
consequence of that link is that negative psychological
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immune function, which in turn may have an effect on the
course of disease. A number of medical conditions
including HIV infection, cancer, and autoimmune dis-
eases have been studied using animal models as well as
clinically to document the negative effects of stress on
physical disease states. A comprehensive review of
clinical research in this field can be found in the text
Human Psychoneuroimmunology [2]b yD r .K a v i t a
Vedhara from the University of Bristol and Michael Irwin,
M.D. of the Cousin’s Center for Psychoneuroimmunology
at University of California, Los Angeles. In this mono-
graph, I present a historical review of how physicians have
deviated from a more holistic approach to healing over
time. My article focuses on pathophysiological mecha-
nisms of stress and how these mechanisms may impact
ocular disease states.
Keratitis sicca was investigated by Ming Jing with a
mouse model to investigate Chinese herbs, and a clinical
study led by Namtran Pham studied the effects of
acupuncture for dry eye. Jing worked with Lei-huo-jiu,
which is made up of 30 types of herbs delivered using a
moxibustion technique over both eyes in humans.
Lei-huo-jiu is thought to adjust ocular perfusion and its
effect is thought to be similar to that of acupuncture.
Using a nonobese diabetic mouse model of Sjogren’s
syndrome, Ming Jing reported the benefits of Lei-huo-jiu
therapy alone vs combination with herbal therapy. In the
mouse, a smoking box was devised to deliver the agents.
The lacrimal gland was excised and histological as well as
immunohistochemical studies were performed using Image
Plus Pro to afford a quantitative measure of interleukin-1,
tumor necrosis factor alpha-1, and nuclear factor kappa B in
the specimens. She showed reduction of all three cytokines
in the combined therapy group compared to controls.
Lei-huo-jiu therapy has been described to have effects
that are similar to those of acupuncture, and it was shown to
be efficacious in this animal model of keratitis sicca as
presented by Jing. Empirical study of Lei-huo-jiu therapy in
the Chinese literature has been touted to enhance circula-
tion rapidly. Acupuncture has been proposed to enhance
parasympathetic tone in the various meridia where it is
applied. The relationship between Lei-huo-jiu therapy and
acupuncture may be that they are both enhancers of
parasympathetic tone. One may ask why would this be
beneficial for the dry eye? A recent publication by Liu et al.
[3] confirmed the presence of all five subtypes of
muscarinic cholinergic receptors in human corneal limbal
and conjunctival epithelial cells, conjunctival goblet cells,
and corneal endothelial cells. Not only are the muscarinic
receptor subtypes widely distributed in corneal and
conjunctival tissues but their natural ligand, acetylcholine,
is also abundant on the ocular surface—secreted by
parasympathetic neurons and ocular surface epithelial cells
[4]. Furthermore, Liu showed that activation of muscarinic
receptors by carbachol led to increased conjunctival
epithelial cell proliferation [3]. The discovery of corneal
muscarinic receptors was provocative as a possible
mechanism of action of how acupuncture or Lei-huo-jiu
therapy may favorably impact the ocular surface in the
study presented here by Jin Ming.
Embracing well-established disease models to conduct
carefully controlled studies, four investigators suggested a
promising prospect for using naturopathic compounds
in the treatment of retinal neurodegenerative diseases.
Wolfberry—commercially called goji berry—is the com-
mon name for the fruit of two very closely related species
Lycium barbarum and Lycium chinense. Renowned in Asia
as a highly nutritious food, wolfberries have been used in
traditional Chinese medicine to improve vision for more
than 2,500 years. Since the early twenty-first century in the
USA and other such developed countries, there has been
rapidly growing recognition of wolfberries for their nutrient
value and antioxidant qualities, leading to a profusion of
consumer products. Such rapid commercial development
extends from wolfberry having a high ranking among super
fruits [5], and it is expected to be part of a multibillion
dollar market by 2011 [6, 7]. A clinical study by Amagase
and Nance in 2008 showed that the daily consumption of L.
barbarum delivered in a standardized juice preparation for
14 days increases subjective feelings of general well-being
and improves neurological/psychological performance and
gastrointestinal functions [8]. L. barbarum polysacchar-
ides as a food supplement have been shown in several
studies to have a complex range of immunomodulatory
effects. Kwok-Fai So’s group evaluated the modulation
of L. barbarum polysaccharides on retinal microglia and
its neuroprotective effect on the survival of retinal
ganglion cells (RGCs) using a rat model of chronic ocular
hypertension. He showed that oral administration of L.
barbarum in Sprague–Dawley rats (250–280 g) signifi-
cantly reduced the loss of RGCs in the face of elevated
intraocular pressure.
For hundreds of years, Chinese physicians have used
chuanxiong for treatment of stroke and heart and kidney
conditions [9]. Chuanxiong is a frequently used Chinese
herb, also called ligustrazine, which has the chemical name
tetramethylpyrazine (TMP). Studies indicate that TMP
treatments improve cardiac and cerebral blood flow and
enhance perfusion of the nail bed microcirculation [10, 11].
Working with TMP, Zhiqun Tan fed both 10- and
16-month-old 3xTg Alzheimer’s transgenic mice a diet
containing TMP (300 mg/kg diet) for 2 months. Tan
showed significant amelioration of the Alzheimer’s patho-
logical changes in both brain and retina with TMP
treatment. Tan cites several studies which imply that TMP
96 j ocul biol dis inform (2009) 2:95–97has exhibited a calcium antagonist role in vascular tissues,
functions as an ROS scavenger, and inhibits inflammatory
events in vivo possibly through modulating secretion of
specific cytokines and nitric oxide-related pathways.
Use of extracts of Cistanche tubelosa for eye disease has
been documented as early as 1644 in the Shenshi Yaohan
by Fu Renyu where it is an important part of a treatment for
several conditions that may include glaucoma and macular
degeneration. Colin Barnstable tested extracts of C.
tubelosa on retinal ganglion cell line RGC5. The extracts
increased mitochondrial membrane potential and resulted in
an increased expression of a several genes, including a
number coding for mitochondrial proteins that include
subunits of ATP synthase, citrate synthase, and SOD1.
Barnstable has shown that the survival of retinal neurons
under a variety of stresses can be dramatically improved by
a number of dietary compounds which have effects on
mitochondria.
Bear bile has been included in Asian pharmacopoeias for
thousands of years in the treatment of several diseases.
Tauroursodeoxycholic acid (TUDCA) and ursodeoxycholic
acid are the major hydrophilic bile acids of bear bile. Both
of these are available as synthetic formulations and are
approved by the health administrations of several countries
for treatment of cirrhosis and gallstones. Jeffrey Boatright,
in an elegant study, showed that treatment with TUDCA is
protective in whole animal and cell culture models of
retinal degeneration.
The fine efforts of these investigators have been published
here to showcase how the door to scientific scrutiny has been
flung open to the realm of complementary medicine in
ophthalmology to invite others in vision research to follow
suit.
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